AbbVie Inc. (ABBV) Earnings History
Earnings Pressure16 years of earnings data (2010–2025) · 5-year EPS trend is negative
Loading earnings history...
AbbVie Inc. (ABBV) Earnings Overview
As of July 8, 2026, AbbVie Inc. (ABBV) reported trailing twelve-month net income of $3.64B, reflecting -0.8% year-over-year growth. The company earned $2.05 per diluted share over the past four quarters, with a net profit margin of 6.9%.
Looking at the long-term picture, ABBV's 5-year EPS compound annual growth rate (CAGR) stands at -2.7%, signaling declining earnings. The company achieved its highest annual net income of $11.84B in fiscal 2022.
AbbVie Inc. maintains positive profitability with a gross margin of 70.2%, operating margin of 32.8%, and net margin of 6.9%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including JNJ ($21.04B net income, 28.5% margin), MRK ($8.94B net income, 28.1% margin), PFE ($7.49B net income, 12.4% margin), ABBV has room to improve margins relative to the peer group. Compare ABBV vs JNJ →
ABBV Earnings vs Peers
Earnings metrics vs comparable public companies
ABBV Historical Earnings Data (2010–2025)
16 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4.23B | -1.2% | $20.09B | $2.37 | 6.9% | 32.8% |
| 2024 | $4.28B | -12.0% | $9.14B | $2.39 | 7.6% | 16.2% |
| 2023 | $4.86B | -58.9% | $12.76B | $2.72 | 9.0% | 23.5% |
| 2022 | $11.84B | +2.5% | $18.12B | $6.63 | 20.4% | 31.2% |
| 2021 | $11.54B | +150.0% | $17.92B | $6.45 | 20.5% | 31.9% |
| 2020 | $4.62B | -41.4% | $11.36B | $2.72 | 10.1% | 24.8% |
| 2019 | $7.88B | +38.6% | $12.98B | $5.28 | 23.7% | 39.0% |
| 2018 | $5.69B | +7.1% | $6.38B | $3.68 | 17.4% | 19.5% |
| 2017 | $5.31B | -10.8% | $9.54B | $3.30 | 18.8% | 33.8% |
| 2016 | $5.95B | +15.7% | $9.34B | $3.63 | 23.2% | 36.4% |
| 2015 | $5.14B | +190.0% | $7.54B | $3.13 | 22.5% | 33.0% |
| 2014 | $1.77B | -57.0% | $3.41B | $1.10 | 8.9% | 17.1% |
| 2013 | $4.13B | -21.7% | $5.66B | $2.56 | 22.0% | 30.1% |
| 2012 | $5.28B | +53.7% | $5.82B | $3.35 | 28.7% | 31.6% |
| 2011 | $3.43B | -17.8% | $3.62B | $2.11 | 19.7% | 20.8% |
| 2010 | $4.18B | - | $4.72B | $2.57 | 26.7% | 30.2% |
Download Data
Export ABBV earnings history in CSV or JSON format
Free sign-in required to download data
Should I Buy ABBV?
Wall Street verdict, signals, and target summaries.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
16+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ABBV — Frequently Asked Questions
Quick answers to the most common questions about buying ABBV stock.
What is ABBV earnings per share (EPS)?
ABBV trailing twelve-month (TTM) diluted EPS is $2.05, reflecting -0.8% year-over-year growth. The 5-year EPS CAGR is -2.7%. Complete EPS history from 2010 to 2025 is available in the table on this page.
What is AbbVie Inc.'s net income?
AbbVie Inc. (ABBV) trailing twelve-month net income is $3.6B as of 2025. Earnings declined -0.8% year-over-year. AbbVie Inc. has been profitable for 16 consecutive years.
Is ABBV profitable?
Yes, ABBV is profitable with a TTM net income of $3.6B and a net profit margin of +6.9%. AbbVie Inc. has generated profits for 16 consecutive years.
What is ABBV's earnings growth rate?
ABBV compound annual EPS growth rates (CAGR): 1-Year: -0.8%, 3-Year: -29.0%, 5-Year: -2.7%, 10-Year: -2.7%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2010 to 2025.
What are ABBV's profit margins?
AbbVie Inc. net profit margin is +6.9%, operating margin is +32.8%, and gross margin is +70.2%. Margins are within a typical range for the sector. Return on Equity is +6214.7%.
Is ABBV growing earnings?
ABBV earnings growth is slowing. Current YoY EPS growth of -0.8% trails the 5-year CAGR of -2.7%. TTM net income is $3.6B.
What was ABBV's best earnings year?
AbbVie Inc.'s highest annual net income on record is $11.8B, achieved in fiscal year 2022. Earnings history on this page spans 2010 to 2025 and includes all annual and quarterly figures.
What were ABBV's earnings last quarter?
ABBV's most recent reported quarter was Q1 2026. Net income was $699M with diluted EPS of $0.39. For a full breakdown of all quarters, see the quarterly earnings table on this page.